featured
No Significant Increase in the Incidence of Guillain–Barré Syndrome After COVID-19 Vaccination Among Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Vaccine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study
Vaccine 2022 Sep 22;40(40)5791-5797, M Jaffry, F Mostafa, K Mandava, S Rosario, Y Jagarlamudi, K Jaffry, J Kornitzer, K Jedidi, H Khan, N SouayahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.